Like The Herald Business Journal on Facebook!
The Herald of Everett, Washington
Customer service  |  Subscribe   |   Log in or sign up   |   Advertising information   |   Contact us
Heraldnet.com

The top local business stories in your email

Contact Us:

Josh O'Connor
Publisher
Phone: 425-339-3007
joconnor@heraldnet.com

Maureen Bozlinski
General Sales Manager
Phone: 425-339-3445
Fax: 425-339-3049
mbozlinksi@heraldnet.com

Jim Davis
Editor
Phone: 425-339-3097
jdavis@heraldnet.com

Site address:
1800 41st Street, S-300,
Everett, WA 98203

Mailing address:
P.O. Box 930
Everett, WA 98206

HBJ RSS feeds

Pfizer: 5 more countries OK arthritis pill Xeljanz

SHARE: facebook Twitter icon Linkedin icon Google+ icon Email icon
Associated Press
Published:
NEW YORK -- Several more countries have approved Pfizer Inc.'s new rheumatoid arthritis medicine, a twice-a-day pill viewed as a likely big seller.
The world's second-largest drugmaker says its Xeljanz has been approved in Russia, Argentina, Kuwait, the United Arab Emirates and Switzerland, the first European country to allow sales.
Meanwhile, New York-based Pfizer is asking advisers to European Union medical regulators to reconsider their recommendation not to approve the drug.
The advisers said Xeljanz didn't control progression of the immune disorder enough to outweigh serious side effects seen in some patients. Those include blood and other cancers, perforated intestines, tuberculosis and other infections, decreased infection-fighting cells, headaches and diarrhea.
Xeljanz, the first in a new class of drugs, was launched in the U.S. in November. It has been heavily advertised.

MORE HBJ HEADLINES

CALENDAR

Market roundup